XLK vs XLV
Technology Select Sector SPDR Fund vs Health Care Select Sector SPDR Fund
- • XLV pays a higher dividend yield (1.38%).
Side-by-side metrics
| Metric | XLK | XLV |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.08% | 0.08% |
Dividend yield Trailing 12-month yield. | 0.47% | 1.38% |
AUM Assets under management — bigger funds are typically more liquid. | $118.67B | $49.10B |
YTD return | 19.11% | 23.16% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 1.56 | 0.41 |
P/E ratio | 31.05 | 30.63 |
Last price | $176.09 | $187.94 |
Inception | — | — |
Issuer | State Street | State Street |
XLK top holdings
| AAPL | Apple Inc | 15.31% |
| NVDA | NVIDIA Corp | 15.08% |
| MSFT | Microsoft Corp | 11.80% |
| AVGO | Broadcom Inc | 4.72% |
| AMD | Advanced Micro Devices Inc | 4.54% |
| MU | Micron Technology Inc | 4.04% |
| PLTR | Palantir Technologies Inc Ordinary Shares - Class A | 2.61% |
| CSCO | Cisco Systems Inc | 2.54% |
| INTC | Intel Corp | 2.01% |
| AMAT | Applied Materials Inc | 1.91% |
XLV top holdings
| LLY | Eli Lilly and Co | 16.88% |
| JNJ | Johnson & Johnson | 9.80% |
| ABBV | AbbVie Inc | 7.76% |
| MRK | Merck & Co Inc | 5.49% |
| UNH | UnitedHealth Group Inc | 5.44% |
| TMO | Thermo Fisher Scientific Inc | 3.84% |
| AMGN | Amgen Inc | 3.75% |
| GILD | Gilead Sciences Inc | 3.15% |
| ABT | Abbott Laboratories | 2.74% |
| PFE | Pfizer Inc | 2.59% |
About XLK
XLK (Technology Select Sector SPDR Fund) is S&P 500 tech sector pure-play. Managed by State Street, the fund carries $118.7B in assets under management, an expense ratio of 0.08%, a dividend yield of 0.47%. Its largest holding is Apple Inc (AAPL), which represents 15.3% of the portfolio. Technology is the fund's largest sector exposure at 100.0%.
About XLV
XLV (Health Care Select Sector SPDR Fund) is S&P 500 health care sector. Managed by State Street, the fund carries $49.1B in assets under management, an expense ratio of 0.08%, a dividend yield of 1.38%. Its largest holding is Eli Lilly and Co (LLY), which represents 16.9% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.